Phase III trial of tesofensine in patients with obesity (trial 2)
Phase of Trial: Phase III
Latest Information Update: 18 Feb 2016
At a glance
- Drugs Tesofensine (Primary)
- Indications Obesity
- Focus Registrational; Therapeutic Use
- 18 Feb 2016 According to a Saniona media release, this trial is expected to initiate in late 2016.
- 31 May 2011 New trial record
- 26 May 2011 The design of the pivotal phase III programme for tesofensine was revised based on feedback from the US FDA and the EMA.